Sleep Tied to Metabolic Dysfunction-Associated Fatty Liver Disease

TUESDAY, Aug. 2, 2022 (HealthDay News) -- Sleep behaviors are associated with the risk of metabolic dysfunction-associated fatty liver disease (MAFLD), according to a study published online July 28 in the Journal of Clinical Endocrinology & Metabolism.
Jialu Yang, Ph.D., from the Guangdong Provincial Key Laboratory of Food, Nutrition, and Health in Guangzhou, China, and colleagues examined the association between dimensions of sleep behaviors and the risk for MAFLD in a cross-sectional study of 5,011 participants with radiologically diagnosed MAFLD.
The researchers found that after full adjustments, including obesity, there were significant associations seen for late bedtime, snoring, and daytime napping for over 30 minutes with increased risks of MAFLD (odds ratios of 1.37, 1.59, and 1.17, respectively). The highest risk for MAFLD was seen for participants with disturbance in nighttime sleep and prolonged daytime napping (odds ratio, 2.38). A 16 percent reduction in risk of MAFLD was seen for each additional increase of healthy sleep score. People with sedentary lifestyle and central obesity experienced more pronounced adverse effects from poor sleep quality. However, only 20.77 percent of the total effect of sleep quality on MAFLD risk was due to obesity.
"Our study provides evidence that even a moderate improvement in sleep quality is sufficient to reduce the risk for fatty liver disease, especially in those with unhealthy lifestyles," a coauthor said in a statement. "Given that large proportions of subjects suffering from poor sleep quality are underdiagnosed and undertreated, our study calls for more research into this field and strategies to improve sleep quality."
Abstract/Full Text (subscription or payment may be required)
Related Posts
Extreme Heat Exposure Tied to Faster Cognitive Decline in Vulnerable Populations
FRIDAY, Aug. 25, 2023 (HealthDay News) -- Extreme heat exposure can...
Tras un brote infeccioso, los expertos ofrecen orientación sobre el uso seguro de las gotas para los ojos
LUNES, 6 de marzo de 2023 (HealthDay News) -- Un brote de unas infecciones...
Los CDC publican unos cambios propuestos en las directrices sobre los analgésicos opioides
JUEVES, 10 de febrero de 2022 (HealthDay News) -- Los cambios propuestos en las...
Omicron Shows Signs of Ebbing as U.S. Cases Fall, Hospitalizations Level Off
TUESDAY, Jan. 25, 2022 (HealthDay News) -- Weeks after omicron began ravaging...
